Colloidal Gold Lateral Immunochromatography has been used for the product.
The kit is positioned by the risk-screening tool of AD, which is to fill the gap of scale (AD8/MMSE/MOCA) in the field of the screening tool for the cognitive impairment.
The applicable scenario includes:the hospital examination center, the department of neurology, neurosurgery department, geriatric department, cardiovascular department, the whole medical discipline, integrated Traditional and Western medicine department, endocrinology department, mental health department, clinical examination department, etc.
while finally community hospitals, OTC pharmacies, physical examination centers, and so on will be applied in the majority.
The colloidal gold technology is fast, convenient, low-cost and stable, in line with the market position of product.